APA (7th ed.) Citation

Fulcher, G., Mehta, R., Fita, E. G., Ekelund, M., & Bain, S. C. (2019). Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials. Diabetes Therapy, 10(1), 107. https://doi.org/10.1007/s13300-018-0531-0

Chicago Style (17th ed.) Citation

Fulcher, Greg, Roopa Mehta, Edmond G. Fita, Magnus Ekelund, and Stephen C. Bain. "Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials." Diabetes Therapy 10, no. 1 (2019): 107. https://doi.org/10.1007/s13300-018-0531-0.

MLA (9th ed.) Citation

Fulcher, Greg, et al. "Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials." Diabetes Therapy, vol. 10, no. 1, 2019, p. 107, https://doi.org/10.1007/s13300-018-0531-0.